A Study of TAVO101 in Atopic Dermatitis Patients
A Study of TAVO101 in Atopic Dermatitis Patients
Active, not recruiting · NCT06176040 · Registry updated 2024-11-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of TAVO101 in Atopic Dermatitis Patients | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Active, not recruiting | Phase 2 | 2024-11-18 | NCT06176040 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tavotek Biotherapeutics | 3 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Optimal Clinical Trials | Auckland | New Zealand | 2 |
| Royal Melbourne Hospital | Parkville | Australia | 5 |